Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2006-08-29
2006-08-29
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C424S009100, C530S330000
Reexamination Certificate
active
07097824
ABSTRACT:
Tuftsin receptor-specific peptides, peptidomimetics and peptide-like constructs are provided, particularly for use in biological, pharmaceutical and radiopharmaceutical applications, in which the peptide, peptidomimetic or construct is conformationally fixed on complexation of the metal ion-binding portion thereof with a metal ion, resulting in a peptide, peptidomimetic or construct with increased affinity for the tuftsin receptor.
REFERENCES:
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5569745 (1996-10-01), Goodbody et al.
patent: 5891418 (1999-04-01), Sharma
patent: 6027711 (2000-02-01), Sharma
patent: 6551574 (2003-04-01), Sharma
patent: 2003/0165427 (2003-09-01), Sharma
Som et al., “Diagnosis of Osteomyelitis and Soft Tissue Infection Using a TC-99m Labeled Tuftsin-Analog Peptide”,The Journal of Nuclear Medicine, vol. 38: 132P, No. 493.
Jones Dameron L.
Palatin Technologies Inc.
Slusher Stephen A.
LandOfFree
Tuftsin metallopeptide analogs and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tuftsin metallopeptide analogs and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tuftsin metallopeptide analogs and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3604776